Comparative risk of pneumonia and acute exacerbation between P-CAB and PPI use in patients with COPD and GERD
Abstract
Potassium-competitive acid blockers (P-CABs) are newer gastric acid suppressants used to treat gastroesophageal reflux disease (GERD), but evidence regarding their respiratory safety compared with proton pump inhibitors (PPIs) in patients with chronic obstructive pulmonary disease (COPD) remains limited. We conducted a target trial emulation study using the Korean National Health Insurance database. Patients aged ≥40 years with COPD who initiated P-CAB or PPI for GERD between 2019 and 2022 were included. Follow-up continued from treatment initiation until the earliest occurrence of the outcome, treatment discontinuation, switching to another drug class, death, or the end of the study period. The outcome was the occurrence of pneumonia or moderate-to-severe COPD exacerbations. Propensity score matching (1:3) was applied, and hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. Among the 560,987 eligible patients, 4671 P-CAB users and 14,013 PPI users were included after matching. P-CAB was not significantly associated with the risk of respiratory events compared with PPI, but a trend toward lower risks for pneumonia (aHR, 0.76; 95% CI, 0.54-1.07) and severe exacerbations (aHR, 0.60; 95% CI, 0.32-1.14) was observed. In patients with a Charlson Comorbidity Index ≤1, the risk of severe exacerbations was significantly lower (aHR, 0.31; 95% CI, 0.11-0.88). P-CABs showed lower risks of pneumonia and severe exacerbations…
Read the paper
Related studies
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.